Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Story

Hadassah Surgeon Ahmed Eid Performs Life-Saving Surgery on Jerusalem Terror Victim

UPDATE: Sunday morning, Miri and Meir Schwartz, Chen’s parents, were looking cheerful. "We had a wonderful Shabbat," said Miri. "Chen recognized us!"

Dr. Eid

Prof. Ahmed Eid, head of the Department of General Surgery at Hadassah Hospital-Mount Scopus, performed life-saving surgery on Chen Schwartz, the Israeli soldier who was shot twice at close range by a terrorist on a motor scooter in Jerusalem.

The surgery was difficult because of the tremendous damage to his body and massive bleeding, Prof. Eid reported. But, he noted: "We used everything we could to save this man. When you are in such a situation at Hadassah, you know that you will never give up until you find a way to save him."

Surgical Nurse Reuven Gelfond, who headed the Israel Defense Forces’ field hospitals in Haiti and the Philippines, echoed Prof. Eid’s sentiments. The Mt. Scopus health care team, she said, is determined to do the near impossible to save a life.

Although the surgery has alleviated the threat to Chen’s life, he will need further surgery to improve his condition as soon as he is strong enough. Chen, age 19, is now recovering in Hadassah’s Intensive Care Unit, where his parents, sister, and friends are taking turns visiting him.

"The care here is so wonderful," said his mother, Miri Schwartz. "The staff is so embracing. Please pass on my thanks to the Hadassah women and supporters abroad who have created this wonderful hospital. We have no illusions. Without them, our son would have died. He's a strong boy and with God's help and Hadassah's, he's going to make it."

Read in The Times of Israel: Arab doctor saves Jewish soldier hit by Arab bullets. No big deal?

Date: 8/11/2014

More hMedicine Stories

Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America